Guide for Authors
Food and Chemical Toxicology (FCT) publishes original research articles, reviews, and case reports
on the toxic effects,in animals or humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis
on food safety, chemical safety, and other areas of consumer product safety. Research papers with a clear scientific contribution to
the field of food/chemical toxicology will be given preference in the review process. Manuscripts concerning materials/substances of
only local interest for which the chemical composition of the material/substance is not clearly defined will not be considered. In addition
to these areas, papers on industrial and agricultural chemicals and pharmaceuticals are encouraged. Furthermore new areas such as safety
evaluation of novel foods and ingredients and biotechnologically derived products, including nanomaterials and inter-relationships between
nutrition and toxicology are encouraged. Studies should address the physiological, biochemical or pathological changes induced by specific
substances, techniques for assessing potential toxicity, including molecular biology or the mode/mechanisms underlying toxic phenomena.
All aspects of in vivo toxicology are covered, including systemic effects on specific organ systems, immune functions, carcinogenesis
and reproductive/developmental toxicology. Papers reporting the toxicological examination of specific chemicals or consumer products
are published irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards
of scientific adequacy. FCT encourages submission of in vitro papers, particularly those fostering the 3 Rs.
Types of paper
The Journal's main purpose is the publication of papers reporting and interpreting original
unpublished toxicological research, particularly studies promoting an understanding of the mechanisms underlying toxic effects or improvements
in methods for predicting adverse effects. Papers reporting the toxicological examination of specific foods, chemicals or consumer products
will be published, irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards
of acceptability. In addition, Brief Communications will also be considered, as will concise interpretative Reviews of toxicological
topics of contemporary significance. Letters to the Editor will be limited to comments on contributions already published in the journal;
if a letter is accepted, a response (for simultaneous publication) will be invited from the authors of the original contribution. All
Letters to the Editor should be submitted to the Editor in Chief, A. Wallace Hayes at the following address:
awallacehayes@comcast.net.
Page charges
This journal has no page charges.
Ethics in publishing
For information on Ethics in publishing and Ethical
guidelines for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Confict of interest statements for authors
All authors are requested to disclose any actual or potential
conflict of interest including any financial, personal or other relationships with other people or organizations within three years of
beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Food and Chemical Toxicology requires full disclosure of all potential conflicts of interest. Please download the disclosure
from the
Food and Chemical Toxicology web site,
http://ees.elsevier.com/fct at the 'Attach Files' stage of manuscript
submission or download the form directly
here. The corresponding
author is responsible for downloading and sharing a copy of this form for each and every co-author listed on the manuscript. Each and
every co-author must complete and sign their individual form and return to the corresponding author. The corresponding author is responsible
for uploading their form and those of their co-authors (as one document) at the submission process. Investigators should disclose potential
conflicts to participants in clinical trials and other studies and should state in the manuscript whether they have done so.
Food
and Chemical Toxicology may decide not to publish on the basis of a declared conflict, such as the financial interest of an author
in a company (or its competitors) that makes a product discussed in the paper.
Submission
declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including
electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality
detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Submission declaration and verification
Submission of an article implies that the work described has not been published
previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration
for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where
the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language,
including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the
originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Each manuscript must
also be accompanied by a cover letter outlining the basic findings of the paper and their significance. Furthermore, it is understood
that with submission of this article the authors have complied with the institutional policies governing the humane and ethical treatment
of the experimental subjects, and that they are willing to share the original data and materials if so requested.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the
authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove
an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript
and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail,
fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded
by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers
will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until
authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or
rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such
involvement then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This journal offers you the option of making your article freely available to all via the ScienceDirect
platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been
accepted for publication. The fee of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions
and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements
are available at
http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this
option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf). Whatever
access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article
on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally
online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files
to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are
converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All
correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for
a paper trail.
Referees
The Editors require submissions by the authors
of the names and addresses of 4 potential reviewers for this submission. The institutional address and e-mail address are required. At
least 2 of the referees should be from a different country to the corresponding author's. The Editors reserve the right to use these
or other reviewers.
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used.
The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed
and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words.
However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one
grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic
text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication).
Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also
the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections
should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also
for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear
on its own separate line.
Introduction
State the objectives of the
work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already
published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often
appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of
a Discussion or Results and Discussion section.
Essential title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations
and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a
double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names.
Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also
post-publication.
Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address
and the complete postal address. Contact details must be kept up to date by the corresponding author.
•
Present/permanent
address.
If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address'
(or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the
research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able
to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard
or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Graphical abstract
A Graphical abstract is optional and should summarize the contents of the article in
a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide images that clearly represent
the work described in the article. Graphical abstracts should be submitted as a separate file in the online submission system. Image
size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable
at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement
service to ensure the best presentation of their images also in accordance with all technical requirements:
Illustration Service.
Highlights
Please amend
your research highlights so that they consist of 3 to 5 brief bullet points which convey the core findings of your work. Please ensure
EACH bullet point does NOT exceed 125 characters (including spaces). An example is given below:
RESEARCH HIGHLIGHTS EXAMPLE:
* Research highlights are a mandatory field of a submitted paper & therefore should not exceed 125 characters including spaces.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using British spelling and avoiding
general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly
established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Abbreviations should be used sparingly; they should be defined when first used in the paper but also listed
in alphabetical order under
Abbreviations as a footnote to the title page (see above).
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help
during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Nomenclature and units
All measurements should be expressed in metric, preferably SI, units. Test chemicals
and enzymes must be clearly identified, IUPAC and CAS names being used, wherever possible with the aid of CAS Registry and EC numbers.
Pesticides should be referred to be their ISO names and human and veterinary drugs by their INNs.
Database linking and Accession numbers
Elsevier aims at connecting online articles with external databases which are useful
in their respective research communities. If your article contains relevant unique identifiers or accession numbers (bioinformatics)
linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate
those entities according to the standard explained below.
Authors should explicitly mention the
database abbreviation (as mentioned
below) together with the actual database number, bearing in mind that an error in a letter or number can result in a dead link in
the online version of the article.
Please use the following format:
Database ID: xxxx
Links can be provided in your online
article to the following databases (examples of citations are given in parentheses):
•
GenBank:
Genetic sequence database at the National Center for Biotechnical Information (NCBI) (GenBank ID: BA123456)
•
PDB:
Worldwide Protein Data Bank (PDB ID: 1TUP)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
TAIR: The Arabidopsis Information
Resource database (TAIR ID: AT1G01020)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
MINT: Molecular INTeractions
database (MINT ID: 6166710)
•
MI: EMBL-EBI OLS Molecular
Interaction Ontology (MI ID: 0218)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Gene accession numbers
In the electronic version of a published manuscript, gene accession
numbers will be linked directly to the gene's description in NCBI's Nucleotide sequence database. The accession number should be formatted
as follows:
Accession no. AJ315850
and in the text e.g. ". . . at the amino acid sequence level to the human IDN3 gene (Accession
No. AJ315850)."
The production department will then link this reference when they find it in the text. Authors should DOUBLE-CHECK
the number they use to make absolutely sure that it is correct before referring to it in their paper. Accession numbers in proofs should
also always be checked for correctness. The number is an essential part of the link.
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic
numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position
of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference
list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as 'graphics'
or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number
the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
•
Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit
each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless
of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats
(note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings.
Embed the font or save the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a
minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel)
then please supply 'as is'.
Please do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT,
WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately
large for the content.
Color artwork
Please make sure that artwork
files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article,
you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web
(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version.
For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article.
Please indicate your preference for color: in print or on the Web only. For further information on the preparation of electronic artwork,
please see
http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise
by converting color figures to 'gray scale' (for the printed version should you not opt for color in print) please submit in addition
usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a
brief title (
not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum
but explain all symbols and abbreviations used.
Tables
Number tables consecutively
in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase
letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference
list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are
not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they
should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished
results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.
Reference management software
This journal has standard templates available in key reference management
packages EndNote (
http://www.endnote.com/support/enstyles.asp) and Reference Manager (
http://refman.com/support/rmstyles.asp).
Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article
and the list of references and citations to these will be formatted according to the journal style which is described below.
Reference style
Text: All citations in the text should refer to:
1.
Single author:
the author's name (without initials, unless there is ambiguity) and the year of publication;
2.
Two authors: both authors'
names and the year of publication;
3.
Three or more authors: first author's name followed by 'et al.' and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). Kramer et al. (2010) have recently shown ....'
List:
References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from
the same author(s) in the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific article.
J. Sci. Commun. 163, 51–59.
Reference to a book:
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman,
New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of
your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281–304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal
abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video
data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who
have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of
the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content.
In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file
formats with a preferred maximum size of 50 MB. Video and animation files supplied will be published online in the electronic version
of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills'
with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard
icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary
data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files
offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with
the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction
pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please
consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author
has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
•
Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked'
and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference
list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources
(including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the
Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please
visit our customer support site at
http://support.elsevier.com.
Use of
the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The
DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic
publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press'
because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example
taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to
create URL hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an
e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files
themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version
7 (or higher) available free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany
the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully
before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that
Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra
charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF
file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining
the terms and conditions of use.
For inquiries relating
to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising
after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles
at
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ)
and/or contact Customer Support via
http://support.elsevier.com.
